Publications by authors named "David R Wada"

Claim this Profile
A
Application of the model-informed drug development paradigm to datopotamab deruxtecan dose selection for late-stage development.
Yasong Lu, Shuang Liang, Ying Hong, Naoyuki Tajima, Kashyap Patel, David R Wada

CPT Pharmacometrics Syst Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of cabozantinib treatment on QT interval in a phase 3 study in medullary thyroid cancer: evaluation of indirect QT effects mediated through treatment-induced changes in serum electrolytes.
Dale R Miles, Steven A Lacy, David R Wada, Steve Milwee, Yifah Yaron

Cancer Chemother Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic/pharmacodynamic modeling of tumor growth kinetics in medullary thyroid cancer patients receiving cabozantinib.
Dale R Miles, David R Wada, Nelson L Jumbe, Steven A Lacy, Linh T Nguyen

Anticancer Drugs· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis